<!DOCTYPE html><html lang="en-us" >


<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  
  
  
    <meta name="generator" content="Wowchemy 5.5.0 for Hugo" />
  

  
  










  







  
  
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
  

  
  
  
    
      
      <link rel="preload" as="style" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap">
      <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Montserrat:wght@400;700&family=Roboto+Mono&family=Roboto:wght@400;700&display=swap" media="print" onload="this.media='all'">
    
  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Chris Oldmeadow" />

  
  
  
    
  
  <meta name="description" content="Background Access to opioid agonist treatment can be associated with extensive waiting periods with significant health and financial burdens. This study aimed to determine whether patients with heroin dependence dispensed buprenorphine-naloxone weekly have greater reductions in heroin use and related adverse health effects 12-weeks after commencing treatment, compared to waitlist controls and to examine the cost-effectiveness of this strategy. Methods An open-label waitlist RCT was conducted in an opioid treatment clinic in Newcastle, Australia. Fifty patients with DSM-IV-TR heroin dependence (and no other substance dependence) were recruited. The intervention group (n = 25) received take-home self-administered sublingual buprenorphine-naloxone weekly (mean dose, 22.7 ± 5.7 mg) and weekly clinical review. Waitlist controls (n = 25) received no clinical intervention. The primary outcome was heroin use (self-report, urine toxicology verified) at weeks four, eight and 12. The primary cost-effectiveness outcome was incremental cost per additional heroin-free-day. Results Outcome data were available for 80% of all randomized participants. Across the 12-weeks, treatment group heroin use was on average 19.02 days less/month (95% CI −22.98, −15.06, p &lt; 0.0001). A total 12-week reduction in adjusted costs including crime of $A5,722 (95% CI 3299, 8154) in favor of treatment was observed. Excluding crime, incremental cost per heroin-free-day gained from treatment was $A18.24 (95% CI 4.50, 28.49). Conclusion When compared to remaining on a waitlist, take-home self-administered buprenorphine-naloxone treatment is associated with significant reductions in heroin use for people with DSM-IV-TR heroin dependence. This cost-effective approach may be an efficient strategy to enhance treatment capacity." />

  
  <link rel="alternate" hreflang="en-us" href="https://example.com/publication/dunlop-2017-effectivenesstrial/" />

  
  
  
    <meta name="theme-color" content="#1565c0" />
  

  
  

  

  <link rel="stylesheet" href="/css/vendor-bundle.min.c7b8d9abd591ba2253ea42747e3ac3f5.css" media="print" onload="this.media='all'">

  
  
  
    
    
      <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/academicons@1.9.1/css/academicons.min.css" integrity="sha512-W0xM4mr6dEP9nREo7Z9z+9X70wytKvMGeDsj7ps2+xg5QPrEBXC8tAW1IFnzjR6eoJ90JmCnFzerQJTLzIEHjA==" crossorigin="anonymous" media="print" onload="this.media='all'">
    

    
    
    
    
      
      
    
    
    

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/github.min.css" crossorigin="anonymous" title="hl-light" media="print" onload="this.media='all'">
          <link rel="stylesheet" href="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" media="print" onload="this.media='all'" disabled>
        
      
    

    
    
    

    

    
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
      
      

      
      
        
      

      
    
      
      

      
      

      
    
      
      

      
      

      
    
  

  
  
  
  
  
  <link rel="stylesheet" href="/css/wowchemy.1052fab8b7700a3dc49ee23683097d66.css" />

  



  


  


  




  
  
  

  

  
    <link rel="manifest" href="/manifest.webmanifest" />
  

  <link rel="icon" type="image/png" href="/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_32x32_fill_lanczos_center_3.png" />
  <link rel="apple-touch-icon" type="image/png" href="/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_180x180_fill_lanczos_center_3.png" />

  <link rel="canonical" href="https://example.com/publication/dunlop-2017-effectivenesstrial/" />

  
  
  
  
  
  
  
  
    
    
  
  

  
  
    
    
  
  <meta property="twitter:card" content="summary" />
  
    <meta property="twitter:site" content="@wowchemy" />
    <meta property="twitter:creator" content="@wowchemy" />
  
  <meta property="og:site_name" content="Academic" />
  <meta property="og:url" content="https://example.com/publication/dunlop-2017-effectivenesstrial/" />
  <meta property="og:title" content="Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial | Academic" />
  <meta property="og:description" content="Background Access to opioid agonist treatment can be associated with extensive waiting periods with significant health and financial burdens. This study aimed to determine whether patients with heroin dependence dispensed buprenorphine-naloxone weekly have greater reductions in heroin use and related adverse health effects 12-weeks after commencing treatment, compared to waitlist controls and to examine the cost-effectiveness of this strategy. Methods An open-label waitlist RCT was conducted in an opioid treatment clinic in Newcastle, Australia. Fifty patients with DSM-IV-TR heroin dependence (and no other substance dependence) were recruited. The intervention group (n = 25) received take-home self-administered sublingual buprenorphine-naloxone weekly (mean dose, 22.7 ± 5.7 mg) and weekly clinical review. Waitlist controls (n = 25) received no clinical intervention. The primary outcome was heroin use (self-report, urine toxicology verified) at weeks four, eight and 12. The primary cost-effectiveness outcome was incremental cost per additional heroin-free-day. Results Outcome data were available for 80% of all randomized participants. Across the 12-weeks, treatment group heroin use was on average 19.02 days less/month (95% CI −22.98, −15.06, p &lt; 0.0001). A total 12-week reduction in adjusted costs including crime of $A5,722 (95% CI 3299, 8154) in favor of treatment was observed. Excluding crime, incremental cost per heroin-free-day gained from treatment was $A18.24 (95% CI 4.50, 28.49). Conclusion When compared to remaining on a waitlist, take-home self-administered buprenorphine-naloxone treatment is associated with significant reductions in heroin use for people with DSM-IV-TR heroin dependence. This cost-effective approach may be an efficient strategy to enhance treatment capacity." /><meta property="og:image" content="https://example.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_3.png" />
    <meta property="twitter:image" content="https://example.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_3.png" /><meta property="og:locale" content="en-us" />
  
    
      <meta
        property="article:published_time"
        content="2017-05-01T00:00:00&#43;00:00"
      />
    
    <meta property="article:modified_time" content="2017-05-01T00:00:00&#43;00:00">
  

  


    









<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://example.com/publication/dunlop-2017-effectivenesstrial/"
  },
  "headline": "Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial",
  
  "datePublished": "2017-05-01T00:00:00Z",
  "dateModified": "2017-05-01T00:00:00Z",
  
  "author": {
    "@type": "Person",
    "name": "AJ Dunlop"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "Academic",
    "logo": {
      "@type": "ImageObject",
      "url": "https://example.com/media/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_192x192_fill_lanczos_center_3.png"
    }
  },
  "description": "Background Access to opioid agonist treatment can be associated with extensive waiting periods with significant health and financial burdens. This study aimed to determine whether patients with heroin dependence dispensed buprenorphine-naloxone weekly have greater reductions in heroin use and related adverse health effects 12-weeks after commencing treatment, compared to waitlist controls and to examine the cost-effectiveness of this strategy. Methods An open-label waitlist RCT was conducted in an opioid treatment clinic in Newcastle, Australia. Fifty patients with DSM-IV-TR heroin dependence (and no other substance dependence) were recruited. The intervention group (n = 25) received take-home self-administered sublingual buprenorphine-naloxone weekly (mean dose, 22.7 ± 5.7 mg) and weekly clinical review. Waitlist controls (n = 25) received no clinical intervention. The primary outcome was heroin use (self-report, urine toxicology verified) at weeks four, eight and 12. The primary cost-effectiveness outcome was incremental cost per additional heroin-free-day. Results Outcome data were available for 80% of all randomized participants. Across the 12-weeks, treatment group heroin use was on average 19.02 days less/month (95% CI −22.98, −15.06, p \u003c 0.0001). A total 12-week reduction in adjusted costs including crime of $A5,722 (95% CI 3299, 8154) in favor of treatment was observed. Excluding crime, incremental cost per heroin-free-day gained from treatment was $A18.24 (95% CI 4.50, 28.49). Conclusion When compared to remaining on a waitlist, take-home self-administered buprenorphine-naloxone treatment is associated with significant reductions in heroin use for people with DSM-IV-TR heroin dependence. This cost-effective approach may be an efficient strategy to enhance treatment capacity."
}
</script>

  

  

  

  





  <title>Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial | Academic</title>
</head>


<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" class="page-wrapper   " data-wc-page-id="109733ce4d76a9078066f04d55c16dcf" >

  
  
  
  
  
  
  
  
  
  <script src="/js/wowchemy-init.min.2ed908358299dd7ab553faae685c746c.js"></script>

  


<aside class="search-modal" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#" aria-label="Close"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search" class="form-control"
        aria-label="Search...">
        
      </div>

      
      

      

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>



  <div class="page-header">
    












<header class="header--fixed">
  <nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id="navbar-main">
    <div class="container-xl">

      
      <div class="d-none d-lg-inline-flex">
        <a class="navbar-brand" href="/">Academic</a>
      </div>
      

      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar-content" aria-controls="navbar-content" aria-expanded="false" aria-label="Toggle navigation">
      <span><i class="fas fa-bars"></i></span>
      </button>
      

      
      <div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none">
        <a class="navbar-brand" href="/">Academic</a>
      </div>
      

      
      
      <div class="navbar-collapse main-menu-item collapse justify-content-start" id="navbar-content">

        
        <ul class="navbar-nav d-md-inline-flex">
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#about"><span>Home</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#posts"><span>Posts</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#projects"><span>Projects</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#talks"><span>Talks</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#featured"><span>Publications</span></a>
          </li>

          
          

          

          
          
          
            
          

          

          
          
          
          

          
            
              
              
            
            
              
              
              
                
              
              
            
          

          <li class="nav-item">
            <a class="nav-link " href="/#contact"><span>Contact</span></a>
          </li>

          
          

        

          
        </ul>
      </div>

      <ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2">

        
        
          
        

        
        
        <li class="nav-item">
          <a class="nav-link js-search" href="#" aria-label="Search"><i class="fas fa-search" aria-hidden="true"></i></a>
        </li>
        

        
        
        
        <li class="nav-item dropdown theme-dropdown">
          <a href="#" class="nav-link" data-toggle="dropdown" aria-haspopup="true" aria-label="Display preferences">
            <i class="fas fa-moon" aria-hidden="true"></i>
          </a>
          <div class="dropdown-menu">
            <a href="#" class="dropdown-item js-set-theme-light">
              <span>Light</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-dark">
              <span>Dark</span>
            </a>
            <a href="#" class="dropdown-item js-set-theme-auto">
              <span>Automatic</span>
            </a>
          </div>
        </li>
        

        
        

      </ul>

    </div>
  </nav>
</header>


  </div>

  <div class="page-body">
    
    
    

    








<div class="pub">

  












  

  
  
  
<div class="article-container pt-3">
  <h1>Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial</h1>

  

  
    


<div class="article-metadata">

  
  
  
  
  <div>
    

  <span >
      AJ Dunlop</span>, <span >
      AL Brown</span>, <span >
      C Oldmeadow</span>, <span >
      A Harris</span>, <span >
      A Gill</span>, <span >
      C Sadler</span>, <span >
      K Ribbons</span>, <span >
      J Attia</span>, <span >
      D Barker</span>, <span >
      P Ghijben</span>, <span >
      J Hinman</span>, <span >
      M Jackson</span>, <span >
      J Bell</span>, <span >
      N Lintzeris</span>
  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    May, 2017
  </span>
  

  

  

  
  
  
  

  
  

</div>

    




<div class="btn-links mb-3">
  
  








  

















<a class="btn btn-outline-primary btn-page-header" href="https://doi.org/10.1016/j.drugalcdep.2017.01.016" target="_blank" rel="noopener">
  DOI
</a>



</div>


  
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Background Access to opioid agonist treatment can be associated with extensive waiting periods with significant health and financial burdens. This study aimed to determine whether patients with heroin dependence dispensed buprenorphine-naloxone weekly have greater reductions in heroin use and related adverse health effects 12-weeks after commencing treatment, compared to waitlist controls and to examine the cost-effectiveness of this strategy. Methods An open-label waitlist RCT was conducted in an opioid treatment clinic in Newcastle, Australia. Fifty patients with DSM-IV-TR heroin dependence (and no other substance dependence) were recruited. The intervention group (n = 25) received take-home self-administered sublingual buprenorphine-naloxone weekly (mean dose, 22.7 ± 5.7 mg) and weekly clinical review. Waitlist controls (n = 25) received no clinical intervention. The primary outcome was heroin use (self-report, urine toxicology verified) at weeks four, eight and 12. The primary cost-effectiveness outcome was incremental cost per additional heroin-free-day. Results Outcome data were available for 80% of all randomized participants. Across the 12-weeks, treatment group heroin use was on average 19.02 days less/month (95% CI −22.98, −15.06, p &lt; 0.0001). A total 12-week reduction in adjusted costs including crime of $A5,722 (95% CI 3299, 8154) in favor of treatment was observed. Excluding crime, incremental cost per heroin-free-day gained from treatment was $A18.24 (95% CI 4.50, 28.49). Conclusion When compared to remaining on a waitlist, take-home self-administered buprenorphine-naloxone treatment is associated with significant reductions in heroin use for people with DSM-IV-TR heroin dependence. This cost-effective approach may be an efficient strategy to enhance treatment capacity.</p>
    

    
    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            <a href="/publication/#2">
              Journal article
            </a>
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9"><em>Drug and Alcohol Dependence</em></div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    






<div class="share-box">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=https://example.com/publication/dunlop-2017-effectivenesstrial/&amp;text=Effectiveness%20and%20cost-effectiveness%20of%20unsupervised%20buprenorphine-naloxone%20for%20the%20treatment%20of%20heroin%20dependence%20in%20a%20randomized%20waitlist%20controlled%20trial" target="_blank" rel="noopener" class="share-btn-twitter" aria-label="twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=https://example.com/publication/dunlop-2017-effectivenesstrial/&amp;t=Effectiveness%20and%20cost-effectiveness%20of%20unsupervised%20buprenorphine-naloxone%20for%20the%20treatment%20of%20heroin%20dependence%20in%20a%20randomized%20waitlist%20controlled%20trial" target="_blank" rel="noopener" class="share-btn-facebook" aria-label="facebook">
          <i class="fab fa-facebook"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Effectiveness%20and%20cost-effectiveness%20of%20unsupervised%20buprenorphine-naloxone%20for%20the%20treatment%20of%20heroin%20dependence%20in%20a%20randomized%20waitlist%20controlled%20trial&amp;body=https://example.com/publication/dunlop-2017-effectivenesstrial/" target="_blank" rel="noopener" class="share-btn-email" aria-label="envelope">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=https://example.com/publication/dunlop-2017-effectivenesstrial/&amp;title=Effectiveness%20and%20cost-effectiveness%20of%20unsupervised%20buprenorphine-naloxone%20for%20the%20treatment%20of%20heroin%20dependence%20in%20a%20randomized%20waitlist%20controlled%20trial" target="_blank" rel="noopener" class="share-btn-linkedin" aria-label="linkedin-in">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="whatsapp://send?text=Effectiveness%20and%20cost-effectiveness%20of%20unsupervised%20buprenorphine-naloxone%20for%20the%20treatment%20of%20heroin%20dependence%20in%20a%20randomized%20waitlist%20controlled%20trial%20https://example.com/publication/dunlop-2017-effectivenesstrial/" target="_blank" rel="noopener" class="share-btn-whatsapp" aria-label="whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=https://example.com/publication/dunlop-2017-effectivenesstrial/&amp;title=Effectiveness%20and%20cost-effectiveness%20of%20unsupervised%20buprenorphine-naloxone%20for%20the%20treatment%20of%20heroin%20dependence%20in%20a%20randomized%20waitlist%20controlled%20trial" target="_blank" rel="noopener" class="share-btn-weibo" aria-label="weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>











  
  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
    




  
















  </div>
</div>
  </div>

  <div class="page-footer">
    
    
    <div class="container">
      <footer class="site-footer">

  



  

  

  

  
  






  
  
  

  
  
    
  
  
    
  

  

  
  <p class="powered-by copyright-license-text">
    © 2022 Me. This work is licensed under <a href="https://creativecommons.org/licenses/by-nc-nd/4.0" rel="noopener noreferrer" target="_blank">CC BY NC ND 4.0</a>
  </p>
  

  <p class="powered-by footer-license-icons">
    <a href="https://creativecommons.org/licenses/by-nc-nd/4.0" rel="noopener noreferrer" target="_blank" aria-label="Creative Commons">
      <i class="fab fa-creative-commons fa-2x" aria-hidden="true"></i>
      <i class="fab fa-creative-commons-by fa-2x" aria-hidden="true"></i>
      
        <i class="fab fa-creative-commons-nc fa-2x" aria-hidden="true"></i>
      
      
        <i class="fab fa-creative-commons-nd fa-2x" aria-hidden="true"></i>
      
    </a>
  </p>




  <p class="powered-by">
    
    
    
      
      
      
      
      
      
      Published with <a href="https://wowchemy.com/?utm_campaign=poweredby" target="_blank" rel="noopener">Wowchemy</a> — the free, <a href="https://github.com/wowchemy/wowchemy-hugo-themes" target="_blank" rel="noopener">open source</a> website builder that empowers creators.
    
  </p>
</footer>

    </div>
    
  </div>

      

    
    <script src="/js/vendor-bundle.min.46271ef31da3f018e9cd1b59300aa265.js"></script>

    
    
    
      

      
      

      

      
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/highlight.min.js" integrity="sha512-Ypjm0o7jOxAd4hpdoppSEN0TQOC19UtPAqD+4s5AlXmUvbmmS/YMxYqAqarQYyxTnB6/rqip9qcxlNB/3U9Wdg==" crossorigin="anonymous"></script>
        
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/r.min.js" crossorigin="anonymous"></script>
        
        <script src="https://cdn.jsdelivr.net/gh/highlightjs/cdn-release@10.2.1/build/languages/latex.min.js" crossorigin="anonymous"></script>
        
      

    

    
    
    

    
    

    
    
    
      
      <script id="search-hit-fuse-template" type="text/x-template">
        <div class="search-hit" id="summary-{{key}}">
          <div class="search-hit-content">
            <div class="search-hit-name">
              <a href="{{relpermalink}}">{{title}}</a>
              <div class="article-metadata search-hit-type">{{type}}</div>
              <p class="search-hit-description">{{snippet}}</p>
            </div>
          </div>
        </div>
      </script>
      
        <script src="https://cdn.jsdelivr.net/gh/krisk/Fuse@v3.2.1/dist/fuse.min.js" integrity="sha512-o38bmzBGX+hD3JHWUFCDA09btWaqrNmoJ3RXLlrysA7PP01Kgs4UlE4MhelE1v5dJR3+cxlR4qQlotsW7jKsnw==" crossorigin="anonymous"></script>
        <script src="https://cdn.jsdelivr.net/gh/julmot/mark.js@8.11.1/dist/jquery.mark.min.js" integrity="sha512-mhbv5DqBMgrWL+32MmsDOt/OAvqr/cHimk6B8y/bx/xS88MVkYGPiVv2ixKVrkywF2qHplNRUvFsAHUdxZ3Krg==" crossorigin="anonymous"></script>
      
    

    
    

    
    
    
    

    
    
      
      
      
      
      
      
      
    

    

    
    
    
    <script id="page-data" type="application/json">{"use_headroom":true}</script>

    
    
      <script src="/js/wowchemy-headroom.c251366b4128fd5e6b046d4c97a62a51.js" type="module"></script>
    
    
    
    
    
    
    
      
      
    
    
    <script src="/en/js/wowchemy.min.3239609ca7abe02ed52d76ffcb22af1d.js"></script>

    
    
    
    
    
    
      
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

      <script src="/js/wowchemy-publication.68f8d7090562ca65fc6d3cb3f8f2d2cb.js" type="module"></script>






</body>
</html>
